Citation 132548

MARTIN,MW: O'SULLIVAN,A: GOMPERTS,BD:. (1995). INHIBITION BY CROMOGLYCATE AND SOME FLAVONOIDS OF NUCLEOSIDE DIPHOSPHATE KINASE AND OF EXOCYTOSIS FROM PERMEABILIZED MAST CELLS.. 115(6)

Citation Details

Title	INHIBITION BY CROMOGLYCATE AND SOME FLAVONOIDS OF NUCLEOSIDE DIPHOSPHATE KINASE AND OF EXOCYTOSIS FROM PERMEABILIZED MAST CELLS.
Authors	MARTIN,MW: O'SULLIVAN,A: GOMPERTS,BD:
Year	1995
Volume	115
Issue	6

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
2	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
3	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
4	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	WEAK ACTIVITY
5	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
6	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
7	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
8	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
9	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
10	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
11	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
12	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
13	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	ACTIVE
14	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	INACTIVE
15	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	ACTIVE
16	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	ACTIVE
17	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	ACTIVE
18	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	ACTIVE
19	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
20	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	ACTIVE
21	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	ACTIVE
22	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	ACTIVE
23	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
24	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
25	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
26	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
27	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
28	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
29	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
30	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
31	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
32	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
33	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
34	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
35	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
36	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
37	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
38	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
39	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	INACTIVE
40	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORIZIN	ACTIVE
41	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORIZIN	ACTIVE
42	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORIZIN	ACTIVE
43	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORIZIN	ACTIVE
44	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORIZIN	ACTIVE
45	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
46	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
47	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMOGLYCATE*	INACTIVE
48	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMOGLYCATE*	INACTIVE
49	KINASE ACTIVITY INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMOGLYCATE*	INACTIVE
50	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMOGLYCATE*	ACTIVE
51	CELL TRANSPORT EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	CHROMOGLYCATE*	ACTIVE

Citation 132548

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1